Caitlin Gibson, PharmD, BCPS

Assistant Professor of Pharmacotherapy C Gibson


Education & Experience:

I received my PharmD from the University of Texas at Austin. I completed a PGY-1 Pharmacy Residency at the Veterans Affairs North Texas Health Care System/Texas Tech University Health Sciences Center School of Pharmacy. I then completed a PGY-2 specialty residency in Internal Medicine at Indiana University Health/Butler University College of Pharmacy and Health Sciences. I joined the faculty at UNT SCP in 2014 as a clinical faculty member. I spend 40% of my time working and teaching as a clinical pharmacist at Medical City Arlington, where I provide team-based care to patients admitted to the Cardiovascular ICU and Telemetry units.

Teaching Areas & Interests:

My primary teaching assignments include teaching and directing the Renal and Cardiovascular Integrated Pharmacotherapy courses at UNT. I also co-direct an Advanced Cardiovascular elective for P3 students. I am also involved in Interprofessional Education on campus. I take P4 students on Acute Care (Internal Medicine) and Cardiology rotations at my practice site, Medical City Arlington. I also precept the Medical City Arlington PGY1 resident on their Academia, Internal Medicine, and Cardiology rotations.

Professional Activities & Awards:

I am an active member of the American College of Clinical Pharmacy (ACCP), American Association of Colleges of Pharmacy (AACP), Phi Delta Chi Professional Pharmacy Fraternity, and Texas Society of Health-System Pharmacists (TSHP). I am also a member of Phi Lambda Sigma and Rho Chi. I serve as primary advisor for the UNT Chapters of Phi Delta Chi and Rho Chi Pharmaceutical Honor Society. I was the 2015-2016 recipient of the UNT Pharmacotherapy “Faculty of the Year” teaching award, and the 2018 recipient of the M.E.T. Award for “Outstanding Junior Faculty Achievement.”

Scholarly Interests:

My primary areas of scholarly interest include cardiovascular disease and educational research. I have published several times in the area of anticoagulation, with a specific interest in the feasibility, effectiveness, and safety of direct oral anticoagulants in real-life practice. I am currently completing a prospective clinical study comparing two different deep vein thrombosis dosing strategies in morbidly obese patients. I am also interested in health disparities in cardiovascular disease and treatments and well as mitigating post-operative complications after coronary artery bypass graft surgery. My education research has centered around cultural competency and bringing simulation activities to the classroom.

Recent Publications:

Gibson CM, Smith CB, Scalese M. Assessment of apixaban prescribing patterns for non-valvular atrial fibrillation in hospitalized patients. Ann Pharmacother. 2018; 52:54-59.

Gibson CM, Basto AN, Howard ML. Direct oral anticoagulants in cardioversion: a review of current evidence. Ann Pharmacother. 2018;52:277-284.

Gibson CM, Davis S, Bradford D. Examining the use of sodium nitroprusside in coronary artery bypass grafting: is the benefit worth the cost? Hosp Pharmacy. 2017; 52(7):502-7.

Gibson CM, Finks S. Edoxaban: How does the newest agent fit into the DOAC landscape? Am J Med. 2017; 130(8):900-906.

Gibson CM, Elrod S. Student versus residency program perceptions of a high-quality PGY1 residency applicant. Curr Pharm Teach Learn. 2017. ePub ahead of print. DOI:10.1016/j.cptl.2017.10.006.

Link to Dr. Gibson’s University Profile

This page was last modified on October 19, 2018